ID   M3K2_HUMAN              Reviewed;         619 AA.
AC   Q9Y2U5; B9EG87; Q53QL9; Q53S75; Q59GZ6; Q8NC32; Q9NYK3;
DT   30-MAY-2000, integrated into UniProtKB/Swiss-Prot.
DT   16-MAY-2006, sequence version 2.
DT   15-MAR-2017, entry version 180.
DE   RecName: Full=Mitogen-activated protein kinase kinase kinase 2;
DE            EC=2.7.11.25;
DE   AltName: Full=MAPK/ERK kinase kinase 2;
DE            Short=MEK kinase 2;
DE            Short=MEKK 2;
GN   Name=MAP3K2; Synonyms=MAPKKK2, MEKK2;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RA   Su B., Yang J.H., Xia Y., Karin M.;
RT   "MEKK2 is involved in transducing T-cell co-stimulatory signals to the
RT   JNK cascade.";
RL   Submitted (DEC-1998) to the EMBL/GenBank/DDBJ databases.
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   TISSUE=T-cell;
RA   Wang C., Lo H.;
RT   "Cloning of human MEKK2b cDNA.";
RL   Submitted (FEB-2000) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Brain;
RA   Totoki Y., Toyoda A., Takeda T., Sakaki Y., Tanaka A., Yokoyama S.,
RA   Ohara O., Nagase T., Kikuno R.F.;
RL   Submitted (MAR-2005) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15815621; DOI=10.1038/nature03466;
RA   Hillier L.W., Graves T.A., Fulton R.S., Fulton L.A., Pepin K.H.,
RA   Minx P., Wagner-McPherson C., Layman D., Wylie K., Sekhon M.,
RA   Becker M.C., Fewell G.A., Delehaunty K.D., Miner T.L., Nash W.E.,
RA   Kremitzki C., Oddy L., Du H., Sun H., Bradshaw-Cordum H., Ali J.,
RA   Carter J., Cordes M., Harris A., Isak A., van Brunt A., Nguyen C.,
RA   Du F., Courtney L., Kalicki J., Ozersky P., Abbott S., Armstrong J.,
RA   Belter E.A., Caruso L., Cedroni M., Cotton M., Davidson T., Desai A.,
RA   Elliott G., Erb T., Fronick C., Gaige T., Haakenson W., Haglund K.,
RA   Holmes A., Harkins R., Kim K., Kruchowski S.S., Strong C.M.,
RA   Grewal N., Goyea E., Hou S., Levy A., Martinka S., Mead K.,
RA   McLellan M.D., Meyer R., Randall-Maher J., Tomlinson C.,
RA   Dauphin-Kohlberg S., Kozlowicz-Reilly A., Shah N.,
RA   Swearengen-Shahid S., Snider J., Strong J.T., Thompson J., Yoakum M.,
RA   Leonard S., Pearman C., Trani L., Radionenko M., Waligorski J.E.,
RA   Wang C., Rock S.M., Tin-Wollam A.-M., Maupin R., Latreille P.,
RA   Wendl M.C., Yang S.-P., Pohl C., Wallis J.W., Spieth J., Bieri T.A.,
RA   Berkowicz N., Nelson J.O., Osborne J., Ding L., Meyer R., Sabo A.,
RA   Shotland Y., Sinha P., Wohldmann P.E., Cook L.L., Hickenbotham M.T.,
RA   Eldred J., Williams D., Jones T.A., She X., Ciccarelli F.D.,
RA   Izaurralde E., Taylor J., Schmutz J., Myers R.M., Cox D.R., Huang X.,
RA   McPherson J.D., Mardis E.R., Clifton S.W., Warren W.C.,
RA   Chinwalla A.T., Eddy S.R., Marra M.A., Ovcharenko I., Furey T.S.,
RA   Miller W., Eichler E.E., Bork P., Suyama M., Torrents D.,
RA   Waterston R.H., Wilson R.K.;
RT   "Generation and annotation of the DNA sequences of human chromosomes 2
RT   and 4.";
RL   Nature 434:724-731(2005).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Testis;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 180-619.
RC   TISSUE=Teratocarcinoma;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [8]
RP   FUNCTION, AND INTERACTION WITH MAP2K7 AND MAPK8.
RX   PubMed=10713157; DOI=10.1128/MCB.20.7.2334-2342.2000;
RA   Cheng J., Yang J., Xia Y., Karin M., Su B.;
RT   "Synergistic interaction of MEK kinase 2, c-Jun N-terminal kinase
RT   (JNK) kinase 2, and JNK1 results in efficient and specific JNK1
RT   activation.";
RL   Mol. Cell. Biol. 20:2334-2342(2000).
RN   [9]
RP   SUBCELLULAR LOCATION.
RX   PubMed=15075238; DOI=10.1242/jcs.01040;
RA   Raviv Z., Kalie E., Seger R.;
RT   "MEK5 and ERK5 are localized in the nuclei of resting as well as
RT   stimulated cells, while MEKK2 translocates from the cytosol to the
RT   nucleus upon stimulation.";
RL   J. Cell Sci. 117:1773-1784(2004).
RN   [10]
RP   FUNCTION.
RX   PubMed=16001074; DOI=10.1038/nature03866;
RA   Pelkmans L., Zerial M.;
RT   "Kinase-regulated quantal assemblies and kiss-and-run recycling of
RT   caveolae.";
RL   Nature 436:128-133(2005).
RN   [11]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=17081983; DOI=10.1016/j.cell.2006.09.026;
RA   Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P.,
RA   Mann M.;
RT   "Global, in vivo, and site-specific phosphorylation dynamics in
RT   signaling networks.";
RL   Cell 127:635-648(2006).
RN   [12]
RP   UBIQUITINATION BY XIAP/BIRC4, AND INTERACTION WITH XIAP/BIRC4.
RX   PubMed=18761086; DOI=10.1016/j.cellsig.2008.08.004;
RA   Winsauer G., Resch U., Hofer-Warbinek R., Schichl Y.M., de Martin R.;
RT   "XIAP regulates bi-phasic NF-kappaB induction involving physical
RT   interaction and ubiquitination of MEKK2.";
RL   Cell. Signal. 20:2107-2112(2008).
RN   [13]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-297, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18220336; DOI=10.1021/pr0705441;
RA   Cantin G.T., Yi W., Lu B., Park S.K., Xu T., Lee J.-D.,
RA   Yates J.R. III;
RT   "Combining protein-based IMAC, peptide-based IMAC, and MudPIT for
RT   efficient phosphoproteomic analysis.";
RL   J. Proteome Res. 7:1346-1351(2008).
RN   [14]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Platelet;
RX   PubMed=18088087; DOI=10.1021/pr0704130;
RA   Zahedi R.P., Lewandrowski U., Wiesner J., Wortelkamp S., Moebius J.,
RA   Schuetz C., Walter U., Gambaryan S., Sickmann A.;
RT   "Phosphoproteome of resting human platelets.";
RL   J. Proteome Res. 7:526-534(2008).
RN   [15]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-153; SER-331 AND
RP   SER-344, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE
RP   ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18691976; DOI=10.1016/j.molcel.2008.07.007;
RA   Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R.,
RA   Greff Z., Keri G., Stemmann O., Mann M.;
RT   "Kinase-selective enrichment enables quantitative phosphoproteomics of
RT   the kinome across the cell cycle.";
RL   Mol. Cell 31:438-448(2008).
RN   [16]
RP   INTERACTION WITH STK38, AND SELF-ASSOCIATION.
RX   PubMed=17906693; DOI=10.1038/sj.onc.1210828;
RA   Enomoto A., Kido N., Ito M., Morita A., Matsumoto Y., Takamatsu N.,
RA   Hosoi Y., Miyagawa K.;
RT   "Negative regulation of MEKK1/2 signaling by serine-threonine kinase
RT   38 (STK38).";
RL   Oncogene 27:1930-1938(2008).
RN   [17]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-153; SER-159 AND
RP   SER-164, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE
RP   ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [18]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-26; SER-153; SER-331 AND
RP   SER-344, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE
RP   ANALYSIS].
RX   PubMed=19369195; DOI=10.1074/mcp.M800588-MCP200;
RA   Oppermann F.S., Gnad F., Olsen J.V., Hornberger R., Greff Z., Keri G.,
RA   Mann M., Daub H.;
RT   "Large-scale proteomics analysis of the human kinome.";
RL   Mol. Cell. Proteomics 8:1751-1764(2009).
RN   [19]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-239; SER-331 AND
RP   SER-344, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE
RP   ANALYSIS].
RC   TISSUE=Leukemic T-cell;
RX   PubMed=19690332; DOI=10.1126/scisignal.2000007;
RA   Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,
RA   Rodionov V., Han D.K.;
RT   "Quantitative phosphoproteomic analysis of T cell receptor signaling
RT   reveals system-wide modulation of protein-protein interactions.";
RL   Sci. Signal. 2:RA46-RA46(2009).
RN   [20]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-153, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=20068231; DOI=10.1126/scisignal.2000475;
RA   Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L.,
RA   Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S.,
RA   Mann M.;
RT   "Quantitative phosphoproteomics reveals widespread full
RT   phosphorylation site occupancy during mitosis.";
RL   Sci. Signal. 3:RA3-RA3(2010).
RN   [21]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21406692; DOI=10.1126/scisignal.2001570;
RA   Rigbolt K.T., Prokhorova T.A., Akimov V., Henningsen J.,
RA   Johansen P.T., Kratchmarova I., Kassem M., Mann M., Olsen J.V.,
RA   Blagoev B.;
RT   "System-wide temporal characterization of the proteome and
RT   phosphoproteome of human embryonic stem cell differentiation.";
RL   Sci. Signal. 4:RS3-RS3(2011).
RN   [22]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-153; SER-239; SER-311
RP   AND SER-331, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE
RP   ANALYSIS].
RC   TISSUE=Cervix carcinoma, and Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [23]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-331, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [24]
RP   STRUCTURE BY NMR OF 43-132.
RG   RIKEN structural genomics initiative (RSGI);
RT   "Solution structure of the PB1 domain of human protein kinase
RT   MEKK2B.";
RL   Submitted (NOV-2005) to the PDB data bank.
RN   [25]
RP   VARIANTS [LARGE SCALE ANALYSIS] VAL-110; ILE-112 AND GLY-140.
RX   PubMed=17344846; DOI=10.1038/nature05610;
RA   Greenman C., Stephens P., Smith R., Dalgliesh G.L., Hunter C.,
RA   Bignell G., Davies H., Teague J., Butler A., Stevens C., Edkins S.,
RA   O'Meara S., Vastrik I., Schmidt E.E., Avis T., Barthorpe S.,
RA   Bhamra G., Buck G., Choudhury B., Clements J., Cole J., Dicks E.,
RA   Forbes S., Gray K., Halliday K., Harrison R., Hills K., Hinton J.,
RA   Jenkinson A., Jones D., Menzies A., Mironenko T., Perry J., Raine K.,
RA   Richardson D., Shepherd R., Small A., Tofts C., Varian J., Webb T.,
RA   West S., Widaa S., Yates A., Cahill D.P., Louis D.N., Goldstraw P.,
RA   Nicholson A.G., Brasseur F., Looijenga L., Weber B.L., Chiew Y.-E.,
RA   DeFazio A., Greaves M.F., Green A.R., Campbell P., Birney E.,
RA   Easton D.F., Chenevix-Trench G., Tan M.-H., Khoo S.K., Teh B.T.,
RA   Yuen S.T., Leung S.Y., Wooster R., Futreal P.A., Stratton M.R.;
RT   "Patterns of somatic mutation in human cancer genomes.";
RL   Nature 446:153-158(2007).
CC   -!- FUNCTION: Component of a protein kinase signal transduction
CC       cascade. Regulates the JNK and ERK5 pathways by phosphorylating
CC       and activating MAP2K5 and MAP2K7 (By similarity). Plays a role in
CC       caveolae kiss-and-run dynamics. {ECO:0000250,
CC       ECO:0000269|PubMed:10713157, ECO:0000269|PubMed:16001074}.
CC   -!- CATALYTIC ACTIVITY: ATP + a protein = ADP + a phosphoprotein.
CC   -!- COFACTOR:
CC       Name=Mg(2+); Xref=ChEBI:CHEBI:18420;
CC   -!- ENZYME REGULATION: Activated by phosphorylation on Thr-524.
CC       {ECO:0000250}.
CC   -!- SUBUNIT: Interacts with PKN2; the interaction activates PKN2
CC       kinase activity in a MAP3K2-independent kinase activity (By
CC       similarity). Self-associates. Binds both upstream activators and
CC       downstream substrates in multimolecular complexes. Interacts (via
CC       the kinase catalytic domain) with STK38. Interacts with
CC       XIAP/BIRC4. {ECO:0000250, ECO:0000269|PubMed:10713157,
CC       ECO:0000269|PubMed:17906693, ECO:0000269|PubMed:18761086}.
CC   -!- INTERACTION:
CC       P31947:SFN; NbExp=2; IntAct=EBI-357393, EBI-476295;
CC       Q9UNE7:STUB1; NbExp=9; IntAct=EBI-357393, EBI-357085;
CC   -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:15075238}.
CC       Nucleus {ECO:0000269|PubMed:15075238}. Note=Upon EGF stimulation,
CC       translocates into the nucleus.
CC   -!- PTM: Autophosphorylated. {ECO:0000250}.
CC   -!- PTM: Ubiquitination by XIAP/BIRC4 does not lead to proteasomal
CC       degradation. {ECO:0000269|PubMed:18761086}.
CC   -!- SIMILARITY: Belongs to the protein kinase superfamily. STE Ser/Thr
CC       protein kinase family. MAP kinase kinase kinase subfamily.
CC       {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=BAC11348.1; Type=Erroneous initiation; Evidence={ECO:0000305};
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AF111105; AAD28547.1; -; mRNA.
DR   EMBL; AF239798; AAF63496.1; -; mRNA.
DR   EMBL; AB208963; BAD92200.1; -; mRNA.
DR   EMBL; AC068282; AAY15043.1; -; Genomic_DNA.
DR   EMBL; AC110926; AAY15070.1; -; Genomic_DNA.
DR   EMBL; CH471103; EAW95315.1; -; Genomic_DNA.
DR   EMBL; BC136293; AAI36294.1; -; mRNA.
DR   EMBL; AK075004; BAC11348.1; ALT_INIT; mRNA.
DR   CCDS; CCDS46404.1; -.
DR   RefSeq; NP_006600.3; NM_006609.4.
DR   UniGene; Hs.145605; -.
DR   PDB; 2CU1; NMR; -; A=43-132.
DR   PDB; 2NPT; X-ray; 1.75 A; B/D=26-123.
DR   PDB; 5EX0; X-ray; 2.70 A; D=256-265.
DR   PDB; 5HQ8; X-ray; 1.72 A; I/J=250-264.
DR   PDBsum; 2CU1; -.
DR   PDBsum; 2NPT; -.
DR   PDBsum; 5EX0; -.
DR   PDBsum; 5HQ8; -.
DR   ProteinModelPortal; Q9Y2U5; -.
DR   SMR; Q9Y2U5; -.
DR   BioGrid; 115969; 36.
DR   DIP; DIP-39756N; -.
DR   IntAct; Q9Y2U5; 17.
DR   MINT; MINT-272127; -.
DR   STRING; 9606.ENSP00000343463; -.
DR   BindingDB; Q9Y2U5; -.
DR   ChEMBL; CHEMBL5914; -.
DR   DrugBank; DB06616; Bosutinib.
DR   GuidetoPHARMACOLOGY; 2077; -.
DR   iPTMnet; Q9Y2U5; -.
DR   PhosphoSitePlus; Q9Y2U5; -.
DR   BioMuta; MAP3K2; -.
DR   DMDM; 97536681; -.
DR   EPD; Q9Y2U5; -.
DR   MaxQB; Q9Y2U5; -.
DR   PaxDb; Q9Y2U5; -.
DR   PeptideAtlas; Q9Y2U5; -.
DR   PRIDE; Q9Y2U5; -.
DR   DNASU; 10746; -.
DR   Ensembl; ENST00000344908; ENSP00000343463; ENSG00000169967.
DR   Ensembl; ENST00000409947; ENSP00000387246; ENSG00000169967.
DR   GeneID; 10746; -.
DR   KEGG; hsa:10746; -.
DR   UCSC; uc002toj.3; human.
DR   CTD; 10746; -.
DR   DisGeNET; 10746; -.
DR   GeneCards; MAP3K2; -.
DR   H-InvDB; HIX0002433; -.
DR   HGNC; HGNC:6854; MAP3K2.
DR   HPA; HPA021540; -.
DR   MIM; 609487; gene.
DR   neXtProt; NX_Q9Y2U5; -.
DR   OpenTargets; ENSG00000169967; -.
DR   PharmGKB; PA30598; -.
DR   eggNOG; KOG0198; Eukaryota.
DR   eggNOG; ENOG410XQGS; LUCA.
DR   GeneTree; ENSGT00800000124036; -.
DR   HOVERGEN; HBG006303; -.
DR   InParanoid; Q9Y2U5; -.
DR   KO; K04420; -.
DR   OMA; RSVHMKS; -.
DR   OrthoDB; EOG091G038L; -.
DR   PhylomeDB; Q9Y2U5; -.
DR   TreeFam; TF105113; -.
DR   BRENDA; 2.7.12.2; 2681.
DR   SignaLink; Q9Y2U5; -.
DR   SIGNOR; Q9Y2U5; -.
DR   ChiTaRS; MAP3K2; human.
DR   EvolutionaryTrace; Q9Y2U5; -.
DR   GeneWiki; MAP3K2; -.
DR   GenomeRNAi; 10746; -.
DR   PRO; PR:Q9Y2U5; -.
DR   Proteomes; UP000005640; Chromosome 2.
DR   Bgee; ENSG00000169967; -.
DR   CleanEx; HS_MAP3K2; -.
DR   ExpressionAtlas; Q9Y2U5; baseline and differential.
DR   Genevisible; Q9Y2U5; HS.
DR   GO; GO:0005737; C:cytoplasm; IBA:GO_Central.
DR   GO; GO:0005829; C:cytosol; IDA:HPA.
DR   GO; GO:0005654; C:nucleoplasm; IDA:HPA.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0004709; F:MAP kinase kinase kinase activity; IEA:UniProtKB-EC.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0004672; F:protein kinase activity; IDA:MGI.
DR   GO; GO:0019901; F:protein kinase binding; IPI:UniProtKB.
DR   GO; GO:0004674; F:protein serine/threonine kinase activity; TAS:ProtInc.
DR   GO; GO:0004702; F:signal transducer, downstream of receptor, with serine/threonine kinase activity; IBA:GO_Central.
DR   GO; GO:0030036; P:actin cytoskeleton organization; IBA:GO_Central.
DR   GO; GO:0007257; P:activation of JUN kinase activity; TAS:ProtInc.
DR   GO; GO:0000187; P:activation of MAPK activity; TAS:ProtInc.
DR   GO; GO:0071260; P:cellular response to mechanical stimulus; IEP:UniProtKB.
DR   GO; GO:0045893; P:positive regulation of transcription, DNA-templated; IDA:UniProtKB.
DR   GO; GO:0006468; P:protein phosphorylation; TAS:ProtInc.
DR   InterPro; IPR011009; Kinase-like_dom.
DR   InterPro; IPR000270; PB1_dom.
DR   InterPro; IPR000719; Prot_kinase_dom.
DR   InterPro; IPR017441; Protein_kinase_ATP_BS.
DR   Pfam; PF00564; PB1; 1.
DR   Pfam; PF00069; Pkinase; 1.
DR   SMART; SM00666; PB1; 1.
DR   SMART; SM00220; S_TKc; 1.
DR   SUPFAM; SSF56112; SSF56112; 1.
DR   PROSITE; PS51745; PB1; 1.
DR   PROSITE; PS00107; PROTEIN_KINASE_ATP; 1.
DR   PROSITE; PS50011; PROTEIN_KINASE_DOM; 1.
PE   1: Evidence at protein level;
KW   3D-structure; ATP-binding; Complete proteome; Cytoplasm; Kinase;
KW   Magnesium; Metal-binding; Nucleotide-binding; Nucleus; Phosphoprotein;
KW   Polymorphism; Reference proteome; Serine/threonine-protein kinase;
KW   Transferase; Ubl conjugation.
FT   CHAIN         1    619       Mitogen-activated protein kinase kinase
FT                                kinase 2.
FT                                /FTId=PRO_0000086243.
FT   DOMAIN       43    122       PB1. {ECO:0000255|PROSITE-
FT                                ProRule:PRU01081}.
FT   DOMAIN      357    617       Protein kinase. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00159}.
FT   NP_BIND     362    371       ATP. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00159}.
FT   ACT_SITE    483    483       Proton acceptor. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00159}.
FT   BINDING     385    385       ATP. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00159}.
FT   MOD_RES      26     26       Phosphoserine.
FT                                {ECO:0000244|PubMed:19369195}.
FT   MOD_RES     135    135       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:Q61084}.
FT   MOD_RES     153    153       Phosphoserine.
FT                                {ECO:0000244|PubMed:18669648,
FT                                ECO:0000244|PubMed:18691976,
FT                                ECO:0000244|PubMed:19369195,
FT                                ECO:0000244|PubMed:20068231,
FT                                ECO:0000244|PubMed:23186163}.
FT   MOD_RES     159    159       Phosphoserine.
FT                                {ECO:0000244|PubMed:18669648}.
FT   MOD_RES     164    164       Phosphoserine.
FT                                {ECO:0000244|PubMed:18669648}.
FT   MOD_RES     239    239       Phosphoserine.
FT                                {ECO:0000244|PubMed:19690332,
FT                                ECO:0000244|PubMed:23186163}.
FT   MOD_RES     297    297       Phosphoserine.
FT                                {ECO:0000244|PubMed:18220336}.
FT   MOD_RES     311    311       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES     331    331       Phosphoserine.
FT                                {ECO:0000244|PubMed:18691976,
FT                                ECO:0000244|PubMed:19369195,
FT                                ECO:0000244|PubMed:19690332,
FT                                ECO:0000244|PubMed:23186163,
FT                                ECO:0000244|PubMed:24275569}.
FT   MOD_RES     344    344       Phosphoserine.
FT                                {ECO:0000244|PubMed:18691976,
FT                                ECO:0000244|PubMed:19369195,
FT                                ECO:0000244|PubMed:19690332}.
FT   MOD_RES     349    349       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:Q61083}.
FT   VARIANT     110    110       I -> V (in dbSNP:rs55767983).
FT                                {ECO:0000269|PubMed:17344846}.
FT                                /FTId=VAR_040682.
FT   VARIANT     112    112       M -> I (in a lung large cell carcinoma
FT                                sample; somatic mutation).
FT                                {ECO:0000269|PubMed:17344846}.
FT                                /FTId=VAR_040683.
FT   VARIANT     140    140       D -> G (in dbSNP:rs56307783).
FT                                {ECO:0000269|PubMed:17344846}.
FT                                /FTId=VAR_040684.
FT   CONFLICT      1      1       M -> GTR (in Ref. 3; BAD92200).
FT                                {ECO:0000305}.
FT   CONFLICT    103    103       V -> L (in Ref. 1; AAD28547 and 2;
FT                                AAF63496). {ECO:0000305}.
FT   CONFLICT    198    198       D -> E (in Ref. 1; AAD28547 and 2;
FT                                AAF63496). {ECO:0000305}.
FT   CONFLICT    225    225       D -> G (in Ref. 1; AAD28547).
FT                                {ECO:0000305}.
FT   CONFLICT    275    277       QEY -> KD (in Ref. 1; AAD28547).
FT                                {ECO:0000305}.
FT   CONFLICT    293    296       TSLR -> NQLT (in Ref. 1; AAD28547 and 2;
FT                                AAF63496). {ECO:0000305}.
FT   CONFLICT    413    413       L -> F (in Ref. 1; AAD28547).
FT                                {ECO:0000305}.
FT   CONFLICT    459    459       V -> G (in Ref. 1; AAD28547).
FT                                {ECO:0000305}.
FT   CONFLICT    480    480       V -> L (in Ref. 1; AAD28547).
FT                                {ECO:0000305}.
FT   CONFLICT    536    536       E -> Q (in Ref. 1; AAD28547 and 2;
FT                                AAF63496). {ECO:0000305}.
FT   CONFLICT    579    579       N -> S (in Ref. 7; BAC11348).
FT                                {ECO:0000305}.
FT   STRAND       44     50       {ECO:0000244|PDB:2NPT}.
FT   STRAND       53     59       {ECO:0000244|PDB:2NPT}.
FT   HELIX        65     76       {ECO:0000244|PDB:2NPT}.
FT   STRAND       80     86       {ECO:0000244|PDB:2NPT}.
FT   STRAND       89     92       {ECO:0000244|PDB:2NPT}.
FT   HELIX        96    108       {ECO:0000244|PDB:2NPT}.
FT   STRAND      114    121       {ECO:0000244|PDB:2NPT}.
FT   STRAND      260    262       {ECO:0000244|PDB:5EX0}.
SQ   SEQUENCE   619 AA;  69741 MW;  E034580D349F097F CRC64;
     MDDQQALNSI MQDLAVLHKA SRPALSLQET RKAKSSSPKK QNDVRVKFEH RGEKRILQFP
     RPVKLEDLRS KAKIAFGQSM DLHYTNNELV IPLTTQDDLD KAVELLDRSI HMKSLKILLV
     INGSTQATNL EPLPSLEDLD NTVFGAERKK RLSIIGPTSR DRSSPPPGYI PDELHQVARN
     GSFTSINSEG EFIPESMDQM LDPLSLSSPE NSGSGSCPSL DSPLDGESYP KSRMPRAQSY
     PDNHQEFSDY DNPIFEKFGK GGTYPRRYHV SYHHQEYNDG RKTFPRARRT QGTSLRSPVS
     FSPTDHSLST SSGSSIFTPE YDDSRIRRRG SDIDNPTLTV MDISPPSRSP RAPTNWRLGK
     LLGQGAFGRV YLCYDVDTGR ELAVKQVQFD PDSPETSKEV NALECEIQLL KNLLHERIVQ
     YYGCLRDPQE KTLSIFMEYM PGGSIKDQLK AYGALTENVT RKYTRQILEG VHYLHSNMIV
     HRDIKGANIL RDSTGNVKLG DFGASKRLQT ICLSGTGMKS VTGTPYWMSP EVISGEGYGR
     KADIWSVACT VVEMLTEKPP WAEFEAMAAI FKIATQPTNP KLPPHVSDYT RDFLKRIFVE
     AKLRPSADEL LRHMFVHYH
//
